首页> 外文OA文献 >Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults

【2h】

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults

机译：HCV E1E2疫苗的安全性和免疫原性辅助MF59给予健康成人

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sharon E. Frey; Michael Houghton; Stephen Coates; Sergio Abrignani; David Chien; Domenico Rosa; Piero Pileri; Ranjit Ray; Adrian M. Di Bisceglie; Paola Rinella; Heather Hill; Mark C. Wolff; Viola Schultze; Jang H. Han; Bruce Scharschmidt; Robert B. Belshe;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults [J] . Frey Sharon E., Houghton Michael, Coates Stephen, Vaccine . 2010,第38期

机译：健康成人服用MF59佐剂的HCV E1E2疫苗的安全性和免疫原性
2. A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59~R-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration [J] . Giovanni Delia Cioppa, Uwe Nicolay, Kelly Lindert Human vaccines . 2014,第6期

机译：一项针对老年人的剂量范围研究，比较了皮内和肌肉内注射MF59〜R佐剂和非佐剂的季节性流感疫苗的安全性和免疫原性
3. A dose-ranging study of MF59~R-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination [J] . Keith S Reisinger, Sra J Holmes, Paola Pedotti, Human vaccines . 2014,第8期

机译：在年轻人至中年和老年人群中进行MF59〜R佐剂和非佐剂的A / H1N1大流行性流感疫苗的剂量范围研究，以评估接种疫苗后一年的安全性，免疫原性和抗体持久性
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. Humoral and cellular immune responses in RNA viral infections: Immunogenicity of HIV-1, HCV and SARS-CoV candidate vaccines in animal models. [D] . Azizi, Ali. 2006

机译：RNA病毒感染中的体液和细胞免疫应答：HIV-1，HCV和SARS-CoV候选疫苗在动物模型中的免疫原性。
6. Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted with MF59 Administered to Healthy Adults [O] . Sharon E. Frey, Michael Houghton, Stephen Coates, -1

机译：HCV E1E2疫苗的安全性和免疫原性辅助MF59给予健康成人
7. A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration [O] . Della Cioppa Giovanni, Nicolay Uwe, Lindert Kelly, 2014

机译：一项针对老年人的剂量范围研究，比较皮内和肌内给药后mF59®-佐剂和非佐剂季节性流感疫苗的安全性和免疫原性特征

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults

著录项

引文网络

相似文献

相关主题

期刊订阅